SIGNET

Signet Therapeutics is an innovative targeted cancer drug development company based on disease models and AI. Signet Therapeutics was founded at the end of 2020, initially established on the campus of Harvard University. Its core team consists of outstanding talents from academia, including Harvard University, the Massachusetts Institute of Technology (MIT), and the Chinese Academy of Sciences, as well as the pharmaceutical industry. The company's headquarters is located in Shenzhen, with a branch in Boston, USA. Signet is not only the phonetic translation of "Signet" but also adheres to the vision of "Hopeful Hearts, Seeking Truth through Observation." Through the professional, cutting-edge, and relentless efforts of its team, Signet aims to bring hope to cancer patients currently without viable treatment options and is committed to transforming highly lethal malignant cancers into manageable chronic diseases through precise targeted therapies.